ID   PHAi002-B
AC   CVCL_YM64
SY   iPSC-QPH02-II; PIDi002-B
DR   hPSCreg; PHAi002-B
DR   Wikidata; Q98128582
RX   PubMed=31689593;
CC   From: Pan-Hammarstrom Laboratory, Karolinska Institutet; Stockholm; Sweden.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31689593
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 13,15
ST   D12S391: 18,25
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D19S433: 13,14
ST   D1S1656: 11,16.3
ST   D21S11: 29,30
ST   D22S1045: 16,17
ST   D2S1338: 17,25
ST   D2S441: 10,14
ST   D3S1358: 13,17
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 11
ST   FGA: 22,24
ST   SE33: 20,25.2
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 14,20
DI   NCIt; C123434; Immunoglobulin A deficiency 1
DI   ORDO; Orphanet_183675; Recurrent infections associated with rare immunoglobulin isotypes deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM63 ! PHAi002-A
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
RX   PubMed=31689593; DOI=10.1016/j.scr.2019.101613;
RA   Arias-Fuenzalida J., Yu J.-W., Du L.-K., Custodio J., Notarangelo L.D.,
RA   Hammarstrom L., Pan-Hammarstrom Q.;
RT   "Generation of human induced pluripotent stem cell lines from patients
RT   with selective IgA deficiency.";
RL   Stem Cell Res. 41:101613-101613(2019).
//